BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 35252434)

  • 1. Early Breast Cancer Evolution by Autosomal Broad Copy Number Alterations.
    Larsen JR; Kuhn P; Hicks JB
    Int J Genomics; 2022; 2022():9332922. PubMed ID: 35252434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CNApp, a tool for the quantification of copy number alterations and integrative analysis revealing clinical implications.
    Franch-Expósito S; Bassaganyas L; Vila-Casadesús M; Hernández-Illán E; Esteban-Fabró R; Díaz-Gay M; Lozano JJ; Castells A; Llovet JM; Castellví-Bel S; Camps J
    Elife; 2020 Jan; 9():. PubMed ID: 31939734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel insights into breast cancer copy number genetic heterogeneity revealed by single-cell genome sequencing.
    Baslan T; Kendall J; Volyanskyy K; McNamara K; Cox H; D'Italia S; Ambrosio F; Riggs M; Rodgers L; Leotta A; Song J; Mao Y; Wu J; Shah R; Gularte-Mérida R; Chadalavada K; Nanjangud G; Varadan V; Gordon A; Curtis C; Krasnitz A; Dimitrova N; Harris L; Wigler M; Hicks J
    Elife; 2020 May; 9():. PubMed ID: 32401198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concurrent DNA Copy-Number Alterations and Mutations in Genes Related to Maintenance of Genome Stability in Uninvolved Mammary Glandular Tissue from Breast Cancer Patients.
    Ronowicz A; Janaszak-Jasiecka A; Skokowski J; Madanecki P; Bartoszewski R; Bałut M; Seroczyńska B; Kochan K; Bogdan A; Butkus M; Pęksa R; Ratajska M; Kuźniacka A; Wasąg B; Gucwa M; Krzyżanowski M; Jaśkiewicz J; Jankowski Z; Forsberg L; Ochocka JR; Limon J; Crowley MR; Buckley PG; Messiaen L; Dumanski JP; Piotrowski A
    Hum Mutat; 2015 Nov; 36(11):1088-99. PubMed ID: 26219265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Luminal breast epithelial cells from wildtype and
    Williams MJ; Oliphant MU; Au V; Liu C; Baril C; O'Flanagan C; Lai D; Beatty S; Van Vliet M; Yiu JC; O'Connor L; Goh WL; Pollaci A; Weiner AC; Grewal D; McPherson A; Moore M; Prabhakar V; Agarwal S; Garber JE; Dillon D; Shah SP; Brugge J; Aparicio S
    bioRxiv; 2024 May; ():. PubMed ID: 38746396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Copy number alterations: a catastrophic orchestration of the breast cancer genome.
    Shahrouzi P; Forouz F; Mathelier A; Kristensen VN; Duijf PHG
    Trends Mol Med; 2024 May; ():. PubMed ID: 38772764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Landscape of somatic allelic imbalances and copy number alterations in HER2-amplified breast cancer.
    Staaf J; Jönsson G; Ringnér M; Baldetorp B; Borg A
    Breast Cancer Res; 2011; 13(6):R129. PubMed ID: 22169037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hierarchical discovery of large-scale and focal copy number alterations in low-coverage cancer genomes.
    Khalil AIS; Khyriem C; Chattopadhyay A; Sanyal A
    BMC Bioinformatics; 2020 Apr; 21(1):147. PubMed ID: 32299346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of gene copy number alterations in DCIS and invasive breast cancer by QM-FISH.
    Pan A; Zhou Y; Mu K; Liu Y; Sun F; Li P; Li L
    Am J Transl Res; 2016; 8(11):4994-5004. PubMed ID: 27904700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrative analysis reveals the direct and indirect interactions between DNA copy number aberrations and gene expression changes.
    Lee H; Kong SW; Park PJ
    Bioinformatics; 2008 Apr; 24(7):889-96. PubMed ID: 18263644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-species DNA copy number analyses identifies multiple 1q21-q23 subtype-specific driver genes for breast cancer.
    Silva GO; He X; Parker JS; Gatza ML; Carey LA; Hou JP; Moulder SL; Marcom PK; Ma J; Rosen JM; Perou CM
    Breast Cancer Res Treat; 2015 Jul; 152(2):347-56. PubMed ID: 26109346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Copy number alterations analysis of primary tumor tissue and circulating tumor cells from patients with early-stage triple negative breast cancer.
    Silvestri M; Dugo M; Vismara M; De Cecco L; Lanzoni D; Vingiani A; Folli S; De Santis MC; de Braud F; Pruneri G; Di Cosimo S; Cappelletti V
    Sci Rep; 2022 Jan; 12(1):1470. PubMed ID: 35087134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determining frequent patterns of copy number alterations in cancer.
    Rapaport F; Leslie C
    PLoS One; 2010 Aug; 5(8):e12028. PubMed ID: 20711339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-resolution detection of copy number alterations in single cells with HiScanner.
    Zhao Y; Luquette LJ; Veit AD; Wang X; Xi R; Viswanadham VV; Shao DD; Walsh CA; Yang HW; Johnson MD; Park PJ
    bioRxiv; 2024 Apr; ():. PubMed ID: 38746445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Broad copy neutral-loss of heterozygosity regions and rare recurring copy number abnormalities in normal karyotype-acute myeloid leukemia genomes.
    Barresi V; Romano A; Musso N; Capizzi C; Consoli C; Martelli MP; Palumbo G; Di Raimondo F; Condorelli DF
    Genes Chromosomes Cancer; 2010 Nov; 49(11):1014-23. PubMed ID: 20725993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decomposing the subclonal structure of tumors with two-way mixture models on copy number aberrations.
    Tai AS; Peng CH; Peng SC; Hsieh WP
    PLoS One; 2018; 13(12):e0206579. PubMed ID: 30540749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Copy number alterations in small intestinal neuroendocrine tumors determined by array comparative genomic hybridization.
    Hashemi J; Fotouhi O; Sulaiman L; Kjellman M; Höög A; Zedenius J; Larsson C
    BMC Cancer; 2013 Oct; 13():505. PubMed ID: 24165089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and genetic characterization of basal cell carcinoma and breast cancer in a single patient.
    Morelle A; Cericatto R; Krepischi AC; Ruiz IR
    Springerplus; 2014; 3():454. PubMed ID: 25184114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of copy number alterations in primary breast tumors of South African patients and their impact on functional cellular pathways.
    Lupicki K; Elifio-Esposito S; Fonseca AS; Weber SH; Sugita B; Langa BC; Pereira SRF; Govender D; Panieri E; Hiss DC; Abdul-Rasool S; Cavalli LR
    Int J Oncol; 2018 Dec; 53(6):2745-2757. PubMed ID: 30320392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of actionable mutations and copy number alterations and the price of a genomic testing panel.
    Shen C; Meric-Bernstam F; Su X; Mendelsohn J; Giordano S
    Oncotarget; 2016 Nov; 7(44):71686-71695. PubMed ID: 27634896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.